Clinical characteristics and treatment-related biomarkers associated with response to high-dose interleukin-2 in metastatic melanoma and renal cell carcinoma: retrospective analysis of an academic community hospital's experience.

Springerplus · 2015 · PMC4366439 · PMID 25815245

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although there appeared to be a difference between prior therapies and response to IL-2 therapy in our cohort, it did not reach statistical significance in either cancer subtype (Tables 2 and 3 ) To date, 6/50 patients (12%) remain disease-free and in complete remission.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.